| NCT Number | NCT05405101 |
| Lead Sponsor | Queen Mary University of London |
| Conditions | Primary Aldosteronism |
| Enrollment | 112 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-11-01 (estimated) |
| Study Completion | 2026-11-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-17 |